Jun Yang

A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile.

Guowang Xu, Hongwei Kong, Hongwei Kong, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer.

Qing Yang, Guowang Xu, Tao Pang, 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases.

Qing Yang, Guowang Xu, Tao Pang, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry.

Xinjie Zhao, Guowang Xu, Tao Pang, 2005, Journal of chromatography. A.

Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis.

Jianren Gu, Guowang Xu, Hongwei Kong, 2005, Analytical chemistry.

High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B.

Peng Gao, Xinjie Zhao, Jiangshan Wang, 2006, Journal of proteome research.

Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles.

Guowang Xu, Guowang Xu, Jun Yang, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.